EDWARD G. BROENNIMAN - Corporate Board Profile

AETHLON MEDICAL INC

Filing Date	Source Excerpt
2005-05-09	Edward G. Broenniman, Director 497,865 shares(7) 2.8% 3030 Bunker Hill Street, Suite 4000, San Diego, CA 92109
2007-02-09	Mr. Broenniman became a director of Aethlon Medical on March 10, 1999. Mr. Broenniman has 35 years of management and executive experience with high-tech, privately-held growth firms where he has served as a CEO, COO, or corporate advisor... The current Audit Committee is comprised of Mr. Barry and Mr. Broenniman. The current Compensation Committee is comprised of Mr. Barry and Mr. Broenniman. Mr. Broenniman is Chairman of the Compensation Committee.
2009-08-04	Mr. Broenniman (age 73) became a director of Aethlon Medical on March 10, 1999. Mr. Broenniman has 30 years of management and executive experience with high-tech, privately held growth firms where he has served as a CEO, COO, or corporate advisor, using his expertise to focus management on increasing profitability and stockholder value. He is the Managing Director of The Piedmont Group, LLC, a venture advisory firm. Mr. Broenniman recently served on the Board of Directors of publicly traded QuesTech (acquired by CACI International), and currently serves on the Boards of four privately held firms. His nonprofit Boards are the Dingman Center for Entrepreneurship’s Board of Advisors at the University of Maryland, the National Association of Corporate Directors, National Capital Chapter and the Board of the Association for Corporate Growth, National Capital Chapter.
2012-04-20	Edward G. Broenniman, Director ... Ellen R Weiner Family Revocable Trust
2016-02-23	Edward G. Broenniman Director 79 ... Mr. Broenniman became a director of Aethlon Medical, Inc. in March 1999. ... Director Compensation for 2015 Fiscal Year ... Edward G. Broenniman (4) $38,000 Fees Earned or Paid in Cash, $30,211 Option Awards, Total $68,211.
2017-02-13	Our Board of Directors presently has an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee, on each of which Messrs. Barry and Broenniman and Dr. Shah serve. Mr. Barry is Chairman of the Audit Committee, Mr. Broenniman is Chairman of the Nominating and Corporate Governance Committee, and Dr. Shah is Chairman of the Compensation Committee. ... The following director compensation disclosure reflects all compensation awarded to, earned by or paid to the directors below for the fiscal year ended March 31, 2016. ... Edward G. Broenniman (4) $38,000 ... Mr. Broenniman received stock option grants of 3,684 shares on June 6, 2014, 8,537 shares on March 14, 2014, and 9,211 shares on July 24, 2012 for his service as an outside director. The June 2014 option vested 3,684 shares on March 31, 2015, the March 2014 option vested all 8,537 shares at grant and the 2012 option vested 3,961 at grant, with 5,250 vesting in the June 2013 quarter. On October 21, 2014 and November 7, 2014, we paid Mr. Broenniman an aggregate of $10,063 for accrued Board of Directors fees and expenses reimbursable to him. In January 2015, we paid $84,500 to Mr. Broenniman in payment of accrued Board of Directors fees and amounts accrued for services rendered to us prior to the 1999 reorganization among Aethlon, Inc., Hemex, Inc. and us. In January 2016 we paid $39,000 to Mr. Broenniman in payment of accrued Board of Directors fees for the fiscal year ended March 31, 2015 and in April 2016 we paid $38,000 to Mr. Broenniman in payment of accrued Board of Directors fees for the fiscal year ended March 31, 2016.
2018-02-16	Edward G. Broenniman Director 81; Board committees: Mr. Broenniman serves as independent director on Audit, Compensation, and Nominating and Corporate Governance Committees; Director Compensation for 2017 Fiscal Year: Fees Earned or Paid in Cash $39,000, Stock Awards $94,438, Total $133,438.
2019-02-22	Mr. Broenniman became a director of Aethlon Medical, Inc. in March 1999. ... In the fiscal year ended March 31, 2018, Mr. Broenniman earned $42,000 related to his role as a Director, a member of our Compensation Committee, and as the chair of our Audit Committee and of our Nominating and Corporate Governance Committee.
2019-09-20	Edward G. Broenniman, Director Mr. Broenniman became a director in March 1999. ... Our Board of Directors presently has an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee, on each of which Drs. Fisher and Shah, Mr. Broenniman and Ms. Johnson serve as independent directors. Director Compensation for 2019 Fiscal Year Mr. Broenniman earned $44,000 related to his role as a director, a member of our Compensation Committee, and as the chair of our Audit Committee and of our Nominating and Corporate Governance Committee. Mr. Broenniman also received RSUs valued at $35,000 for his ongoing service as a Board member per the 2012 Directors Compensation Program.
2020-07-28	Edward G. Broenniman, Director, Age 84. Mr. Broenniman has served as a director of the Company since March 1999. He is Chairman of the Audit Committee and Nominating and Corporate Governance Committee. Director compensation for 2020 fiscal year: $79,000.
2021-07-28	Mr. Broenniman also received RSU’s valued at $35,000 for his ongoing service as a Board member pursuant to the Non-Employee Directors Compensation Program. In the fiscal year ended March 31, 2021, Mr. Broenniman earned $12,500 in cash compensation for his services to us as non-executive Chairman and $60,125 related to his role as a member of our Compensation Committee, and as the chair of our Audit Committee and of our Nominating and Corporate Governance Committee, for an aggregate amount of $72,625.
2022-07-27	In the fiscal year ended March 31, 2022, Mr. Broenniman earned $30,000 in cash compensation for his services to us as non-executive Chairman and $66,750 related to his role as a member of our Compensation Committee, and as the chair of our Audit Committee and of our Nominating and Corporate Governance Committee, for an aggregate amount of $96,750. Mr. Broenniman also received restricted stock units, or RSUs, valued at $50,000 for his ongoing service as a Board member pursuant to our Amended and Restated Non-Employee Director Compensation Policy, or Director Compensation Policy.
2023-07-27	Edward G. Broenniman, Chairman and Director, age 87, served as chair of the Nominating and Corporate Governance Committee until April 26, 2022, and is Chair of the Audit Committee. Director compensation for 2023 fiscal year: $147,500.
2024-08-15	Mr. Broenniman serves as Chairman of our Board and Mr. Frakes as our Interim Chief Executive Officer... Mr. Broenniman is Chair of the Audit Committee... Mr. Broenniman earned $30,000 in cash compensation for his services to us as non-executive Chairman and $67,500 related to his roles as a member of our Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee and as the chair of our Audit Committee, for an aggregate amount of $97,500. Mr. Broenniman also received restricted stock units, or RSUs, valued at $50,000 for his ongoing service as a Board member pursuant to our Amended and Restated Non-Employee Director Compensation Policy.